We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

90 hedge funds and large institutions have $148M invested in Foghorn Therapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

3% more funds holding

Funds holding: 87 → 90 (+3)

0.28% more ownership

Funds ownership: 72.41% → 72.69% (+0.28%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

13% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 30

22% less capital invested

Capital invested by funds: $190M → $148M (-$42.4M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K

Holders
90
Holders Change
+3
Holders Change %
+3.45%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
26
Reduced
30
Closed
5
Calls
–
Puts
$3K
Net Calls
-$3K
Net Calls Change
-$7K

Top Buyers

1
Raymond James Financial
Raymond James Financial
Florida
+$861K
2
DCM
DAFNA Capital Management
California
+$538K
3
SCM
SCS Capital Management
Massachusetts
+$488K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$387K
5
Squarepoint
Squarepoint
New York
+$201K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$460K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$390K
3
Millennium Management
Millennium Management
New York
-$328K
4
BBA
Baker Bros. Advisors
New York
-$213K
5
JP Morgan Chase
JP Morgan Chase
New York
-$184K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$213K -$5 -1 -0%
Renaissance Technologies
27
Renaissance Technologies
New York
$209K +$43.3K +9,500 +20%
Goldman Sachs
28
Goldman Sachs
New York
$206K -$83.5K -18,324 -25%
PAM
29
Panagora Asset Management
Massachusetts
$198K -$3.73K -819 -1%
Qube Research & Technologies (QRT)
30
Qube Research & Technologies (QRT)
United Kingdom
$187K +$6.63K +1,455 +3%
UBS Group
31
UBS Group
Switzerland
$169K +$40.4K +8,863 +24%
Squarepoint
32
Squarepoint
New York
$161K +$201K +44,040 New
Barclays
33
Barclays
United Kingdom
$146K -$53.4K -11,719 -23%
BCM
34
Bridgeway Capital Management
Texas
$143K +$25.5K +5,600 +17%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$132K -$634 -139 -0.4%
TI
36
Trexquant Investment
Connecticut
$130K -$119K -26,013 -42%
Walleye Capital
37
Walleye Capital
New York
$120K -$5.51K -1,209 -4%
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$116K +$73.2K +16,052 +102%
BHCM
39
Brevan Howard Capital Management
Jersey
$104K +$130K +28,606 New
WWA
40
Wingate Wealth Advisors
Massachusetts
$104K – – –
ETC
41
Exchange Traded Concepts
Oklahoma
$101K +$43.8K +9,608 +53%
Bank of America
42
Bank of America
North Carolina
$87K -$35.7K -7,827 -25%
Deutsche Bank
43
Deutsche Bank
Germany
$76.2K +$39.1K +8,580 +70%
Millennium Management
44
Millennium Management
New York
$75.4K -$328K -71,984 -78%
IIM
45
INTECH Investment Management
Florida
$74.7K +$93.3K +20,475 New
Citigroup
46
Citigroup
New York
$68.7K -$5.46K -1,198 -6%
AQR Capital Management
47
AQR Capital Management
Connecticut
$68.2K +$85.2K +18,693 New
HSBC Holdings
48
HSBC Holdings
United Kingdom
$66.6K -$87 -19 -0.1%
AllianceBernstein
49
AllianceBernstein
Tennessee
$63.4K – – –
Wells Fargo
50
Wells Fargo
California
$58.9K +$1.34K +295 +2%
1
2
3 4

FHTX Hedge Fund Activity: Q1 2025 in Review

90 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q1 2025, worth a combined $148M — down 22% from $190M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new FHTX positions and 5 closed out — a net gain of 3 holders — while 26 added to existing stakes and 30 trimmed.

The largest buyer was Raymond James Financial, adding an estimated $861K. The largest seller was Fidelity Investments, cutting an estimated $460K.

  • 90 institutional investors held Foghorn Therapeutics (FHTX) as of Q1 2025, up from 87 in Q4 2024.
  • Funds reported $148M of Foghorn Therapeutics stock for Q1 2025, down 22% quarter-over-quarter.
  • 8 funds opened new Foghorn Therapeutics positions in Q1 2025 and 5 closed out, a net change of +3 holders.
  • The largest Foghorn Therapeutics buyer in Q1 2025 was Raymond James Financial, an estimated $861K added.
  • The largest Foghorn Therapeutics seller in Q1 2025 was Fidelity Investments, an estimated $460K sold.

Based on aggregated 13F filings for Q1 2025.